1. P190 QVA149 Once Daily Provides Significant Improvements in Lung Function Over 1 Year in Patients with COPD: The Enlighten Study. (19th November 2012) Authors: Dahl, R; Chapman, K; Rudolf, M; Mehta, R; Kho, P; Alagappan, V; Berhane, I; Chen, H; Banerji, D Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P194 Once-Daily QVA149 Provides Superior Bronchodilation and Improves Lung Function Versus Twice-Daily Fluticasone/Salmeterol in COPD Patients: The ILLUMINATE Study. (19th November 2012) Authors: Vogelmeier, C; Bateman, E; Pallante, J; Bryant, H; Alagappan, V; D'Andrea, P; He, E; Banerji, D Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S50 Once-daily glycopyrronium improves lung function in COPD patients: pooled results of the GLOW1 and GLOW2 studies. (19th November 2012) Authors: Banerji, D; Alagappan, V; Martin, C; He, E; Chen, H; Overend, T Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗